nodes	percent_of_prediction	percent_of_DWPC	metapath
Lumiracoxib—UGT1A9—Nicotine Metabolism—CYP2A6—hepatitis B	0.0787	0.0854	CbGpPWpGaD
Lumiracoxib—PTGS1—Eicosanoid Synthesis—GGT2—hepatitis B	0.0349	0.0379	CbGpPWpGaD
Lumiracoxib—PTGS2—Eicosanoid Synthesis—GGT2—hepatitis B	0.0277	0.0301	CbGpPWpGaD
Lumiracoxib—CYP1A2—Estrogen Receptor Pathway—NR0B2—hepatitis B	0.0238	0.0259	CbGpPWpGaD
Lumiracoxib—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—CYP2A6—hepatitis B	0.0232	0.0252	CbGpPWpGaD
Lumiracoxib—CYP2C19—CYP2E1 reactions—CYP2A6—hepatitis B	0.0228	0.0247	CbGpPWpGaD
Lumiracoxib—CYP2C9—CYP2E1 reactions—CYP2A6—hepatitis B	0.0208	0.0225	CbGpPWpGaD
Lumiracoxib—UGT1A9—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.0206	0.0224	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aflatoxin activation and detoxification—GGT2—hepatitis B	0.0189	0.0205	CbGpPWpGaD
Lumiracoxib—PTGS1—Eicosanoid Synthesis—GGT1—hepatitis B	0.0165	0.0179	CbGpPWpGaD
Lumiracoxib—UGT1A9—Phase II conjugation—GGT2—hepatitis B	0.0151	0.0164	CbGpPWpGaD
Lumiracoxib—CYP2C19—Xenobiotics—CYP2A6—hepatitis B	0.0141	0.0153	CbGpPWpGaD
Lumiracoxib—CYP2C19—Tamoxifen metabolism—CYP2A6—hepatitis B	0.0136	0.0147	CbGpPWpGaD
Lumiracoxib—CYP1A2—Fatty Acid Omega Oxidation—CYP2A6—hepatitis B	0.0131	0.0143	CbGpPWpGaD
Lumiracoxib—PTGS2—Eicosanoid Synthesis—GGT1—hepatitis B	0.0131	0.0142	CbGpPWpGaD
Lumiracoxib—CYP2C9—Xenobiotics—CYP2A6—hepatitis B	0.0129	0.014	CbGpPWpGaD
Lumiracoxib—CYP2C9—Tamoxifen metabolism—CYP2A6—hepatitis B	0.0124	0.0134	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—GGT2—hepatitis B	0.0123	0.0134	CbGpPWpGaD
Lumiracoxib—CYP2C19—blood plasma—hepatitis B	0.0111	0.14	CbGeAlD
Lumiracoxib—CYP1A2—Xenobiotics—CYP2A6—hepatitis B	0.011	0.0119	CbGpPWpGaD
Lumiracoxib—CYP1A2—Tamoxifen metabolism—CYP2A6—hepatitis B	0.0106	0.0115	CbGpPWpGaD
Lumiracoxib—UGT1A9—NRF2 pathway—GGT2—hepatitis B	0.0101	0.011	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—GGT2—hepatitis B	0.0098	0.0106	CbGpPWpGaD
Lumiracoxib—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.00969	0.0105	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—hepatitis B	0.0093	0.0101	CbGpPWpGaD
Lumiracoxib—PTGS1—Arachidonic acid metabolism—GGT1—hepatitis B	0.00918	0.00997	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metapathway biotransformation—AKR1B1—hepatitis B	0.00911	0.0099	CbGpPWpGaD
Lumiracoxib—CYP1A2—blood plasma—hepatitis B	0.00903	0.114	CbGeAlD
Lumiracoxib—CYP1A2—Aflatoxin activation and detoxification—GGT1—hepatitis B	0.00894	0.00971	CbGpPWpGaD
Lumiracoxib—UGT1A9—Biological oxidations—GGT2—hepatitis B	0.00886	0.00962	CbGpPWpGaD
Lumiracoxib—CYP2C9—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.00883	0.00959	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcium signaling in the CD4+ TCR pathway—FASLG—hepatitis B	0.00865	0.00939	CbGpPWpGaD
Lumiracoxib—CYP2C9—blood plasma—hepatitis B	0.00858	0.109	CbGeAlD
Lumiracoxib—UGT1A9—liver—hepatitis B	0.00853	0.108	CbGeAlD
Lumiracoxib—PTGS1—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.00824	0.00894	CbGpPWpGaD
Lumiracoxib—PTGS1—blood plasma—hepatitis B	0.00783	0.0991	CbGeAlD
Lumiracoxib—PTGS2—blood plasma—hepatitis B	0.00748	0.0947	CbGeAlD
Lumiracoxib—PTGS2—Spinal Cord Injury—MIF—hepatitis B	0.00746	0.0081	CbGpPWpGaD
Lumiracoxib—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—hepatitis B	0.00732	0.00795	CbGpPWpGaD
Lumiracoxib—PTGS2—Arachidonic acid metabolism—GGT1—hepatitis B	0.00729	0.00791	CbGpPWpGaD
Lumiracoxib—PTGS1—Biological oxidations—GGT2—hepatitis B	0.00722	0.00784	CbGpPWpGaD
Lumiracoxib—UGT1A9—Phase II conjugation—GGT1—hepatitis B	0.00716	0.00778	CbGpPWpGaD
Lumiracoxib—PTGS1—Overview of nanoparticle effects—TNF—hepatitis B	0.00625	0.00679	CbGpPWpGaD
Lumiracoxib—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—hepatitis B	0.00613	0.00666	CbGpPWpGaD
Lumiracoxib—UGT1A9—NRF2 pathway—CYP2A6—hepatitis B	0.00612	0.00665	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—hepatitis B	0.00601	0.00653	CbGpPWpGaD
Lumiracoxib—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.00586	0.00636	CbGpPWpGaD
Lumiracoxib—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IFNG—hepatitis B	0.00584	0.00634	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—GGT1—hepatitis B	0.00584	0.00634	CbGpPWpGaD
Lumiracoxib—CYP2C19—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.00578	0.00628	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—hepatitis B	0.00559	0.00607	CbGpPWpGaD
Lumiracoxib—CYP1A2—Phase II conjugation—GGT2—hepatitis B	0.00555	0.00602	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—hepatitis B	0.00547	0.00594	CbGpPWpGaD
Lumiracoxib—UGT1A9—Biological oxidations—CYP2A6—hepatitis B	0.00537	0.00583	CbGpPWpGaD
Lumiracoxib—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.00534	0.0058	CbGpPWpGaD
Lumiracoxib—CYP2C19—Arachidonic acid metabolism—GGT1—hepatitis B	0.00529	0.00575	CbGpPWpGaD
Lumiracoxib—CYP2C9—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.00527	0.00572	CbGpPWpGaD
Lumiracoxib—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL2—hepatitis B	0.00519	0.00564	CbGpPWpGaD
Lumiracoxib—PTGS1—Overview of nanoparticle effects—IL6—hepatitis B	0.00505	0.00548	CbGpPWpGaD
Lumiracoxib—PTGS2—Overview of nanoparticle effects—TNF—hepatitis B	0.00496	0.00539	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—hepatitis B	0.00486	0.00528	CbGpPWpGaD
Lumiracoxib—CYP2C9—Arachidonic acid metabolism—GGT1—hepatitis B	0.00483	0.00524	CbGpPWpGaD
Lumiracoxib—UGT1A9—NRF2 pathway—GGT1—hepatitis B	0.00478	0.00519	CbGpPWpGaD
Lumiracoxib—CYP2C19—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.00475	0.00516	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—GGT1—hepatitis B	0.00464	0.00503	CbGpPWpGaD
Lumiracoxib—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.00457	0.00496	CbGpPWpGaD
Lumiracoxib—CYP1A2—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.00451	0.00489	CbGpPWpGaD
Lumiracoxib—PTGS1—Biological oxidations—CYP2A6—hepatitis B	0.00438	0.00475	CbGpPWpGaD
Lumiracoxib—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.00433	0.0047	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metapathway biotransformation—AKR1B1—hepatitis B	0.00428	0.00465	CbGpPWpGaD
Lumiracoxib—UGT1A9—Biological oxidations—GGT1—hepatitis B	0.00419	0.00455	CbGpPWpGaD
Lumiracoxib—CYP2C19—Biological oxidations—GGT2—hepatitis B	0.00416	0.00452	CbGpPWpGaD
Lumiracoxib—CYP1A2—Arachidonic acid metabolism—GGT1—hepatitis B	0.00412	0.00448	CbGpPWpGaD
Lumiracoxib—CYP2C19—blood—hepatitis B	0.00405	0.0513	CbGeAlD
Lumiracoxib—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TGFB1—hepatitis B	0.00405	0.0044	CbGpPWpGaD
Lumiracoxib—PTGS2—Overview of nanoparticle effects—IL6—hepatitis B	0.00401	0.00435	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metapathway biotransformation—AKR1B1—hepatitis B	0.00391	0.00424	CbGpPWpGaD
Lumiracoxib—CYP2C9—Biological oxidations—GGT2—hepatitis B	0.0038	0.00412	CbGpPWpGaD
Lumiracoxib—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—hepatitis B	0.00378	0.00411	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—F2—hepatitis B	0.00374	0.00406	CbGpPWpGaD
Lumiracoxib—CYP1A2—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.0037	0.00402	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.00355	0.00385	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—hepatitis B	0.00354	0.00384	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—CXCL10—hepatitis B	0.00353	0.00383	CbGpPWpGaD
Lumiracoxib—PTGS1—Biological oxidations—GGT1—hepatitis B	0.00342	0.00371	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—HNF4A—hepatitis B	0.0034	0.00369	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metapathway biotransformation—AKR1B1—hepatitis B	0.00334	0.00362	CbGpPWpGaD
Lumiracoxib—CYP1A2—blood—hepatitis B	0.00331	0.0419	CbGeAlD
Lumiracoxib—CYP2C19—Melatonin metabolism and effects—NFKB1—hepatitis B	0.0033	0.00359	CbGpPWpGaD
Lumiracoxib—CYP1A2—Biological oxidations—GGT2—hepatitis B	0.00324	0.00352	CbGpPWpGaD
Lumiracoxib—CYP2C19—liver—hepatitis B	0.00317	0.0401	CbGeAlD
Lumiracoxib—PTGS2—Aryl Hydrocarbon Receptor—CDKN1A—hepatitis B	0.00317	0.00344	CbGpPWpGaD
Lumiracoxib—PTGS2—Aryl Hydrocarbon Receptor—NFKB1—hepatitis B	0.00315	0.00342	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—hepatitis B	0.00314	0.00341	CbGpPWpGaD
Lumiracoxib—CYP2C9—blood—hepatitis B	0.00314	0.0398	CbGeAlD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—ALB—hepatitis B	0.00311	0.00337	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—F2—hepatitis B	0.00297	0.00322	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.00289	0.00314	CbGpPWpGaD
Lumiracoxib—PTGS1—blood—hepatitis B	0.00287	0.0363	CbGeAlD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—IFNG—hepatitis B	0.00283	0.00308	CbGpPWpGaD
Lumiracoxib—PTGS2—blood—hepatitis B	0.00274	0.0347	CbGeAlD
Lumiracoxib—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—hepatitis B	0.00268	0.00291	CbGpPWpGaD
Lumiracoxib—CYP1A2—Phase II conjugation—GGT1—hepatitis B	0.00262	0.00285	CbGpPWpGaD
Lumiracoxib—CYP1A2—liver—hepatitis B	0.00259	0.0328	CbGeAlD
Lumiracoxib—CYP1A2—Melatonin metabolism and effects—NFKB1—hepatitis B	0.00258	0.0028	CbGpPWpGaD
Lumiracoxib—CYP2C19—Biological oxidations—CYP2A6—hepatitis B	0.00252	0.00274	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—ALB—hepatitis B	0.00247	0.00268	CbGpPWpGaD
Lumiracoxib—CYP2C9—liver—hepatitis B	0.00246	0.0311	CbGeAlD
Lumiracoxib—PTGS2—Aryl Hydrocarbon Receptor—TNF—hepatitis B	0.00245	0.00266	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—TLR4—hepatitis B	0.00244	0.00265	CbGpPWpGaD
Lumiracoxib—PTGS2—C-MYB transcription factor network—CDKN2A—hepatitis B	0.00239	0.0026	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—NFKB1—hepatitis B	0.00236	0.00256	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—NOS2—hepatitis B	0.00232	0.00252	CbGpPWpGaD
Lumiracoxib—CYP2C9—Biological oxidations—CYP2A6—hepatitis B	0.0023	0.0025	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.0023	0.00249	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—hepatitis B	0.00229	0.00249	CbGpPWpGaD
Lumiracoxib—PTGS2—C-MYB transcription factor network—CD4—hepatitis B	0.00226	0.00245	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—IFNG—hepatitis B	0.00225	0.00244	CbGpPWpGaD
Lumiracoxib—PTGS2—liver—hepatitis B	0.00214	0.0271	CbGeAlD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—hepatitis B	0.00214	0.00232	CbGpPWpGaD
Lumiracoxib—CYP2C19—Biological oxidations—GGT1—hepatitis B	0.00197	0.00214	CbGpPWpGaD
Lumiracoxib—CYP1A2—Biological oxidations—CYP2A6—hepatitis B	0.00197	0.00213	CbGpPWpGaD
Lumiracoxib—PTGS2—C-MYB transcription factor network—CDKN1A—hepatitis B	0.00196	0.00212	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—hepatitis B	0.00191	0.00208	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—hepatitis B	0.0019	0.00206	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—NFKB1—hepatitis B	0.00187	0.00203	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—hepatitis B	0.00185	0.002	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—TNF—hepatitis B	0.00183	0.00199	CbGpPWpGaD
Lumiracoxib—CYP2C9—Biological oxidations—GGT1—hepatitis B	0.0018	0.00195	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—hepatitis B	0.00179	0.00195	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—hepatitis B	0.00178	0.00193	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—IFNG—hepatitis B	0.00178	0.00193	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.00167	0.00181	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.00161	0.00175	CbGpPWpGaD
Lumiracoxib—UGT1A9—NRF2 pathway—TGFB1—hepatitis B	0.00161	0.00175	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—IL2—hepatitis B	0.00158	0.00172	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—AKR1B1—hepatitis B	0.00158	0.00172	CbGpPWpGaD
Lumiracoxib—CYP1A2—Biological oxidations—GGT1—hepatitis B	0.00153	0.00167	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.00152	0.00165	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—GGT2—hepatitis B	0.00152	0.00165	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—hepatitis B	0.00148	0.00161	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—IL6—hepatitis B	0.00148	0.00161	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—TNF—hepatitis B	0.00146	0.00158	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—hepatitis B	0.00138	0.0015	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—TNF—hepatitis B	0.00138	0.0015	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—SAG—hepatitis B	0.00135	0.00147	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—APOBEC3G—hepatitis B	0.00135	0.00147	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.00131	0.00142	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.0013	0.00141	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—AKR1B1—hepatitis B	0.00129	0.0014	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—GGT2—hepatitis B	0.00124	0.00134	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—TGFB1—hepatitis B	0.00123	0.00134	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—IL6—hepatitis B	0.00118	0.00128	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—TNF—hepatitis B	0.00115	0.00125	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.00104	0.00113	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	0.00104	0.00113	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—AKR1B1—hepatitis B	0.00102	0.00111	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—TP53—hepatitis B	0.00102	0.0011	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	0.00101	0.0011	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	0.00101	0.0011	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	0.00101	0.00109	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—GGT2—hepatitis B	0.000981	0.00106	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—IL6—hepatitis B	0.000929	0.00101	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—CYP2A6—hepatitis B	0.000918	0.000997	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—ALB—hepatitis B	0.000856	0.000929	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	0.000839	0.000911	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—GOT2—hepatitis B	0.00083	0.000901	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	0.000783	0.000851	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.000756	0.000821	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—CYP2A6—hepatitis B	0.000748	0.000813	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—AKR1B1—hepatitis B	0.000743	0.000807	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—GOT1—hepatitis B	0.000717	0.000778	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—GGT1—hepatitis B	0.000717	0.000778	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—GGT2—hepatitis B	0.000712	0.000773	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—ALB—hepatitis B	0.000698	0.000758	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	0.000691	0.00075	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.00069	0.000749	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—AKR1B1—hepatitis B	0.000677	0.000735	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—GOT2—hepatitis B	0.000677	0.000735	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	0.000653	0.000709	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—GGT2—hepatitis B	0.000649	0.000705	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—GOT2—hepatitis B	0.000642	0.000697	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—CYP2A6—hepatitis B	0.000594	0.000645	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.000589	0.00064	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—GGT1—hepatitis B	0.000584	0.000634	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—GOT1—hepatitis B	0.000584	0.000634	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—AKR1B1—hepatitis B	0.000579	0.000628	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—GGT2—hepatitis B	0.000555	0.000602	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—ALB—hepatitis B	0.000554	0.000601	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—GOT1—hepatitis B	0.000554	0.000601	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—GOT2—hepatitis B	0.000537	0.000583	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	0.000532	0.000578	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—GGT1—hepatitis B	0.000464	0.000504	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—GOT1—hepatitis B	0.000464	0.000504	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—CYP2A6—hepatitis B	0.000431	0.000468	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	0.000423	0.000459	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CCR5—hepatitis B	0.000413	0.000449	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—HLA-A—hepatitis B	0.000403	0.000437	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hepatitis B	0.000402	0.000437	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CYP2A6—hepatitis B	0.000393	0.000427	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—GOT2—hepatitis B	0.00039	0.000424	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—ALB—hepatitis B	0.000381	0.000414	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hepatitis B	0.000367	0.000398	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—GOT2—hepatitis B	0.000356	0.000386	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—NOS2—hepatitis B	0.00035	0.000381	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—GOT1—hepatitis B	0.000337	0.000366	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—GGT1—hepatitis B	0.000337	0.000366	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—CYP2A6—hepatitis B	0.000336	0.000365	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hepatitis B	0.000313	0.00034	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—ALB—hepatitis B	0.000311	0.000337	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—GGT1—hepatitis B	0.000307	0.000333	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—GOT1—hepatitis B	0.000307	0.000333	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	0.000307	0.000333	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—GOT2—hepatitis B	0.000304	0.00033	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PTEN—hepatitis B	0.000291	0.000316	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	0.00028	0.000304	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—GGT1—hepatitis B	0.000262	0.000285	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—GOT1—hepatitis B	0.000262	0.000285	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CD4—hepatitis B	0.00026	0.000282	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—ALB—hepatitis B	0.000247	0.000268	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	0.000239	0.00026	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PTEN—hepatitis B	0.000237	0.000257	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CTNNB1—hepatitis B	0.000231	0.00025	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CDKN1A—hepatitis B	0.000225	0.000245	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—PTEN—hepatitis B	0.000225	0.000244	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PTEN—hepatitis B	0.000188	0.000204	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—TGFB1—hepatitis B	0.000186	0.000202	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—ALB—hepatitis B	0.000179	0.000195	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—ALB—hepatitis B	0.000163	0.000177	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—IL6—hepatitis B	0.00014	0.000152	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—ALB—hepatitis B	0.00014	0.000152	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PTEN—hepatitis B	0.000137	0.000148	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PTEN—hepatitis B	0.000125	0.000135	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PTEN—hepatitis B	0.000107	0.000116	CbGpPWpGaD
